Health - Google News: EU agency backs Novartis' Votubia for kidney tumors - Reuters

Health - Google News Google News

EU agency backs Novartis' Votubia for kidney tumors - Reuters Sep 21st 2012, 12:10 EU agency backs Novartis' Votubia for kidney tumors Reuters | ZURICH (Reuters) - European regulators on Friday recommended approval of a Novartis' drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC). Novartis Reports CHMP Adopts Positive Opinion For Votubia For EU ApprovalRTT News Novartis Reports CHMP Positive Opinions For New Indications Of Galvus & EucreasNASDAQ EU body backs Novartis' Galvus, Eucreas for diabetes indicationsWKZO StreetInsider.com (subscription) -Stock Market Wire -4-traders all 31 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: